Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.9K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.9K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma.

Blood advances·2025
Same author

Evaluating Hospital Course Summarization by an Electronic Health Record-Based Large Language Model.

JAMA network open·2025
Same author

Design and fabrication of a mesoporous silica scaffold for oral delivery of peptides.

Scientific reports·2025
Same author

Vitamin B12 Deficiency in Patients With Diabetic Peripheral Neuropathy: A Hospital-Based Cross-Sectional Study.

Cureus·2025
Same author

Novel insights into ORFV B2L DNA vaccine-mediated gut microbiota modulation and immune augmentation in rats.

Frontiers in immunology·2025
Same author

Disrupting Cell Cycle Machinery: CREPT Is an Emerging Target in Cancer Therapy.

Cancers·2025

Related Experiment Video

Updated: Apr 22, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

7.3K

Recent progress: hematopoietic cell transplant for diffuse large B-cell lymphoma.

Umar Farooq1, Ginna G Laport

  • 1Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics , Iowa City, IA , USA.

Leukemia & Lymphoma
|October 16, 2014
PubMed
Summary

Hematopoietic cell transplant (HCT) is a standard treatment for relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Further research is needed to confirm HCT

Keywords:
Diffuse large cell lymphomaallogeneicautologoustransplant

More Related Videos

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.9K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

14.1K

Related Experiment Videos

Last Updated: Apr 22, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

7.3K
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.9K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

14.1K

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma.
  • Frontline therapy cures approximately 40% of DLBCL patients.
  • Salvage chemotherapy followed by autologous hematopoietic cell transplant (HCT) is the standard for relapsed/refractory chemosensitive disease.

Purpose of the Study:

  • To review the role of HCT in managing DLBCL.
  • To discuss HCT in the context of specific DLBCL subtypes and treatment strategies.

Main Methods:

  • Review of current literature and clinical trial data regarding HCT for DLBCL.
  • Analysis of treatment outcomes based on conditioning regimens and patient subgroups.

Main Results:

  • Autologous HCT in first remission is not recommended due to lack of survival benefit.
  • Allogeneic HCT is typically reserved for specific cases like persistent marrow involvement or post-autologous HCT failure.
  • Reduced intensity conditioning HCT has lower non-relapse mortality but higher relapse rates compared to myeloablative conditioning.

Conclusions:

  • HCT remains a crucial therapeutic option for select DLBCL patients.
  • HCT is often considered consolidation for high-risk subtypes like "double hit" lymphoma.
  • Further studies are required to establish HCT's definitive role in altering the natural history of aggressive DLBCL subtypes.